论文部分内容阅读
约6.6％～12％的小细胞肺癌(SCLC)患者并发上腔静脉梗阻(SVCO)。本文探寻了影响SVCO的疗效、复发时间、总存活期的预后及治疗因素,并评估了治疗对SVCO的复发及顽固状态的影响。 1983年1月～1993年11月,连续收治了446例SCLC病人,其中76例伴有SVCO。1例因资料不全而删掉。依临床、放射影像表现诊断SVCO。CT示所有病人都有纵隔肿块。本文将病变在半胸内及侵及同侧锁骨上淋巴结定为局限期,而将胸内
About 6.6% to 12% of patients with small cell lung cancer (SCLC) complicated with superior vena cava obstruction (SVCO). This article explores the prognostic factors and therapeutic factors that affect the efficacy, relapse time, and overall survival of SVCOs, and evaluates the effect of treatment on the recurrence and obstinate state of SVCO. From January 1983 to November 1993, 446 consecutive patients with SCLC were admitted, 76 of which were associated with SVCO. One case was deleted due to incomplete data. Diagnosis of SVCO based on clinical and radiographic findings. CT showed that all patients had a mediastinal mass. This article defines the lesion in the hemithorax and invades the ipsilateral supraclavicular lymph node as a limitation period, while the intrathoracic